Similar articles for PMID: 28385791

Year	Number of Results
1950	1
1979	1
1999	1
2002	1
2003	1
2006	1
2007	3
2008	1
2010	1
2011	3
2012	3
2013	8
2014	10
2015	5
2016	22
2017	32
2018	32
2019	59
2020	59
2021	53
2022	30
2023	9
2024	1

1

Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using ¹⁸F-Fluciclovine PET/CT.

Miller MP, Kostakoglu L, Pryma D, Yu JQ, Chau A, Perlman E, Clarke B, Rosen D, Ward P. Miller MP, et al. J Nucl Med. 2017 Oct;58(10):1596-1602. doi: 10.2967/jnumed.116.188375. Epub 2017 Apr 6. J Nucl Med. 2017. PMID: 28385791 Free article.

2

Prospective evaluation of fluciclovine (¹⁸F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients.

Akin-Akintayo O, Tade F, Mittal P, Moreno C, Nieh PT, Rossi P, Patil D, Halkar R, Fei B, Master V, Jani AB, Kitajima H, Osunkoya AO, Ormenisan-Gherasim C, Goodman MM, Schuster DM. Akin-Akintayo O, et al. Eur J Radiol. 2018 May;102:1-8. doi: 10.1016/j.ejrad.2018.02.006. Epub 2018 Feb 24. Eur J Radiol. 2018. PMID: 29685521 Free PMC article.

3

Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.

Odewole OA, Tade FI, Nieh PT, Savir-Baruch B, Jani AB, Master VA, Rossi PJ, Halkar RK, Osunkoya AO, Akin-Akintayo O, Zhang C, Chen Z, Goodman MM, Schuster DM. Odewole OA, et al. Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1773-83. doi: 10.1007/s00259-016-3383-8. Epub 2016 Apr 18. Eur J Nucl Med Mol Imaging. 2016. PMID: 27091135 Free PMC article.

4

Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial.

Suzuki H, Jinnouchi S, Kaji Y, Kishida T, Kinoshita H, Yamaguchi S, Tobe T, Okamura T, Kawakita M, Furukawa J, Otaka A, Kakehi Y. Suzuki H, et al. Jpn J Clin Oncol. 2019 Sep 1;49(9):803-811. doi: 10.1093/jjco/hyz072. Jpn J Clin Oncol. 2019. PMID: 31095314 Clinical Trial.

5

Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (¹⁸F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer.

Bach-Gansmo T, Nanni C, Nieh PT, Zanoni L, Bogsrud TV, Sletten H, Korsan KA, Kieboom J, Tade FI, Odewole O, Chau A, Ward P, Goodman MM, Fanti S, Schuster DM, Willoch F. Bach-Gansmo T, et al. J Urol. 2017 Mar;197(3 Pt 1):676-683. doi: 10.1016/j.juro.2016.09.117. Epub 2016 Oct 13. J Urol. 2017. PMID: 27746282 Free PMC article.

6

Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.

Schreibmann E, Schuster DM, Rossi PJ, Shelton J, Cooper S, Jani AB. Schreibmann E, et al. Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):206-13. doi: 10.1016/j.ijrobp.2016.04.023. Epub 2016 Apr 30. Int J Radiat Oncol Biol Phys. 2016. PMID: 27511856 Free PMC article. Clinical Trial.

7

Bayesian penalised likelihood reconstruction (Q.Clear) of ¹⁸F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation.

Teoh EJ, McGowan DR, Schuster DM, Tsakok MT, Gleeson FV, Bradley KM. Teoh EJ, et al. Br J Radiol. 2018 May;91(1085):20170727. doi: 10.1259/bjr.20170727. Epub 2018 Jan 22. Br J Radiol. 2018. PMID: 29303359 Free PMC article.

8

Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for ¹⁸F-fluciclovine-PET/CT in delineating sites of recurrence and identifying patients with oligometastatic disease.

Kim EH, Siegel BA, Teoh EJ, Andriole GL; LOCATE Study Group. Kim EH, et al. Urol Oncol. 2021 Jun;39(6):365.e9-365.e16. doi: 10.1016/j.urolonc.2020.10.017. Epub 2020 Nov 5. Urol Oncol. 2021. PMID: 33160848 Free PMC article.

9

¹⁸F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients.

Selnæs KM, Krüger-Stokke B, Elschot M, Willoch F, Størkersen Ø, Sandsmark E, Moestue SA, Tessem MB, Halvorsen D, Kjøbli E, Angelsen A, Langørgen S, Bertilsson H, Bathen TF. Selnæs KM, et al. Eur Radiol. 2018 Aug;28(8):3151-3159. doi: 10.1007/s00330-017-5213-1. Epub 2018 Jan 2. Eur Radiol. 2018. PMID: 29294158

10

The Clinical Utility of ¹⁸F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval.

Nakamoto R, Harrison C, Song H, Guja KE, Hatami N, Nguyen J, Moradi F, Franc BL, Aparici CM, Davidzon G, Iagaru A. Nakamoto R, et al. Mol Imaging Biol. 2021 Aug;23(4):614-623. doi: 10.1007/s11307-021-01583-3. Epub 2021 Jan 19. Mol Imaging Biol. 2021. PMID: 33469884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

288 results

Results by year